Moreover, Zhu et al. [39] discovered that N-glycosylation of CD82 at Asn157 inhibits EMT by suppressing the Wnt/β-catenin pathway, thereby decreasing metastasis in COAD. Here, CD82 is linked to colon adenocarcinoma.